Niemann-Pick Type C1 deficiency in microglia does not cause neuron death in vitro  by Peake, Kyle B. et al.
Biochimica et Biophysica Acta 1812 (2011) 1121–1129
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbadisNiemann-Pick Type C1 deﬁciency in microglia does not cause neuron death in vitro
Kyle B. Peake a,b, Robert B. Campenot c, Dennis E. Vance a,d,⁎, Jean E. Vance a,b
a Group on the Molecular and Cell Biology of Lipids, University of Alberta, Edmonton, AB, Canada
b Department of Medicine, University of Alberta, Edmonton, AB, Canada
c Department of Cell Biology, University of Alberta, Edmonton, AB, Canada
d Department of Biochemistry, University of Alberta, Edmonton, AB, CanadaAbbreviations: CGCs, cerebellar granule cells; CNS, ce
Dulbecco's modiﬁed Eagle medium; FBS, fetal bovine
binding adaptor molecule 1; IL10, interleukin-10; LE/
MAP2, microtubule-associated protein 2; NPC, Niemann
buffered saline; TNF, tumor necrosis factor
⁎ Corresponding author at: 328 HMRC University of A
Canada. Tel.: +1 780 492 7250; fax: +1 780 492 3383.
E-mail address: jean.vance@ualberta.ca (D.E. Vance)
0925-4439/$ – see front matter © 2011 Elsevier B.V. Al
doi:10.1016/j.bbadis.2011.06.003a b s t r a c ta r t i c l e i n f oArticle history:
Received 27 January 2011
Received in revised form 24 May 2011
Accepted 8 June 2011
Available online 17 June 2011
Keywords:
Niemann-Pick Type C
Microglia
Tumor necrosis factor
Interleukin-10
NeurodegenerationNiemann-Pick TypeC (NPC) disease is an autosomal recessive disorder that results in accumulation of cholesterol
and other lipids in late endosomes/lysosomes and leads to progressive neurodegeneration and premature death.
The mechanism by which lipid accumulation causes neurodegeneration remains unclear. Inappropriate
activation of microglia, the resident immune cells of the central nervous system, has been implicated in several
neurodegenerative disorders including NPC disease. Immunohistochemical analysis demonstrates that NPC1
deﬁciency in mouse brains alters microglial morphology and increases the number of microglia. In primary
cultures of microglia from Npc1−/− mice cholesterol is sequestered intracellularly, as occurs in other NPC-
deﬁcient cells. Activated microglia secrete potentially neurotoxic molecules such as tumor necrosis factor-α
(TNFα). However, NPC1 deﬁciency in isolatedmicroglia did not increase TNFαmRNA or TNFα secretion in vitro.
In addition, qPCR analysis shows that expression of pro-inﬂammatory and oxidative stress genes is the same in
Npc1+/+ andNpc1−/−microglia, whereas themRNA encoding the anti-inﬂammatory cytokine, interleukin-10 in
Npc1−/−microglia is ~60% lower than in Npc1+/+microglia. The survival of cultured neurons was not impaired
by NPC1 deﬁciency, nor was death of Npc1−/− and Npc1+/+ neurons in microglia–neuron co-cultures increased
by NPC1 deﬁciency in microglia. However, a high concentration of Npc1−/− microglia appeared to promote
neuron survival. Thus, althoughmicroglia exhibit an activemorphology in NPC1-deﬁcient brains, lack of NPC1 in
microglia does not promote neuron death in vitro in microglia–neuron co-cultures, supporting the view that
microglial NPC1 deﬁciency is not the primary cause of neuron death in NPC disease.ntral nervous system; DMEM,
serum; Iba1, ionized calcium
L, late endosomes/lysosomes;
-Pick Type C; PBS, phosphate-
lberta Edmonton, AB T6G 2S2
.
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Niemann Pick Type-C (NPC) disease is an autosomal recessive
disorder that is characterized by liver disease, lung disease and
neurodegeneration that lead to premature death (reviewed in [1]).
Mutations in either NPC1 or NPC2 lead to the accumulation of lipids,
particularly cholesterol that is derived from endocytosed lipoproteins
[2], within late endosomes/lysosomes (LE/L) of all cells [3] including
neurons [4] and astrocytes [5]. The two NPC proteins, NPC1 and NPC2,
act in tandem in the LE/L to mediate the egress of cholesterol from the
LE/L [6].
Neuronal death occurs progressively in NPC disease, with Purkinje
neurons of the cerebellum being particularly affected [7,8]. However,
the mechanism underlying the neurodegeneration remains unclear.Apoptotic neurons have been detected by TUNEL staining in the
cerebral cortex and cerebellum of NPC patients and NPC1-deﬁcient
mice [9]. In addition, in the Npc1−/− mouse cerebellum, levels of
mRNAs encoding apoptotic markers such as caspase-1 and -3 are
elevated [8], and the c-Abl/p73 apoptotic pathway is activated [10].
Furthermore, amounts of mRNAs encoding the pro-inﬂammatory
cytokine tumor necrosis factor-α (TNFα) and other components of
the TNF death pathway are increased in the cerebellum of NPC1-null
mice [8,9,11]. The events underlying the increased apoptosis of
neurons in response to NPC deﬁciency have not been elucidated in
detail but might include leakage of lysosomal enzymes and oxidative
stress [12]. In addition, dysfunction of non-neuronal cells in the brain,
such as microglia and/or astrocytes, has been proposed to contribute
to the neurodegeneration that characterizes NPC disease [13,14].
Microglia are resident immune cells of the central nervous system
(CNS) and play a crucial role in maintaining health and function of the
brain. In a healthy brain, the microglia constantly monitor their
surroundings with their ramiﬁed processes [15]. When the microglia
detect disturbances to the brain environment, such as cell damage or an
invading pathogen, the microglia can become activated. Depending
upon the activating stimulus, the microglia invoke various responses
that includemigration to the site of injury [16,17], proliferation [18] and
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generate an inﬂammatory response through the release of pro-
inﬂammatory cytokines [20,21], glutamate [22], reactive oxygen species
[23], and nitric oxide [24]. Although inﬂammation is a mechanism for
protection of the CNS, molecules produced during an inﬂammatory
response are potentially cytotoxic so that the microglia must tightly
control the extent of inﬂammation. Consequently, the microglia also
produce anti-inﬂammatory cytokines and neuroprotective molecules
such as growth factors [25–27] that allow the microglia to shift from a
classical pro-inﬂammatory state to a more neuroprotective state so that
repair and regeneration of damaged tissue can occur [28]. These wide-
ranging capabilities provide the microglia with the ﬁrst line of defense
against a variety of insults to the CNS.
Increasing evidence suggests that chronic activation and/or
dysfunction of microglia can contribute to neuron death in neurode-
generative disorders such as Alzheimer disease and Parkinson disease
(reviewed in [29]). Moreover, replacement of mutant microglia with
wild-typemicroglia by bonemarrow transplantation inmousemodels
of amyotrophic lateral sclerosis and Sandhoff disease (a lysosomal
storage disorder) delayed the onset, and slowed the course, of these
diseases [30,31]. On the other hand, microglial defects are not the
primary determinants of CNS pathology in Gaucher's disease, another
lysosomal lipid storage disease [32]. In the brains of NPC1-deﬁcient
mice the number of microglia is markedly increased and these
microglia exhibit an activated morphology [13,33,34]. Microglia
proliferate in speciﬁc regions of the NPC1-deﬁcient brain, such as the
thalamus and cerebellum, and the activated microglia eventually
spread throughout the brain as the disease progresses [13]. Interest-
ingly, this activation/proliferation of microglia was observed prior to
any detectable neurodegeneration [13], suggesting that microglia
might play a role in initiating the neurodegeneration in NPC disease.
Nevertheless, neuronal damage that was undetectable by the
techniques employed might have contributed to activation of the
microglia. It is also possible that cholesterol sequestration in NPC1-
deﬁcient microglia alters microglial function and renders these cells
less able to perform normal neuroprotective functions.
Thus, the role of microglia in NPC disease is controversial. A key
question is: do activated NPC1-deﬁcient microglia initiate and/or
exacerbate neuronal death, or do microglia become activated in
response to cell death in an attempt to prevent further neuronal
death?We, therefore, investigated the role of microglia in NPC disease
using primary microglia isolated from Npc1−/− and Npc1+/+ mice.
Experiments were performed with co-cultures of primary microglia
and primary neurons to test the hypothesis that NPC1 deﬁciency in
microglia causes neuron death.
2. Materials and methods
2.1. Materials
Dulbecco'sModiﬁed EagleMedium(DMEM)high glucose, Ham's F12
medium,Neurobasalmedium, fetal bovine serum(FBS), B27 supplement
and 0.25% trypsin-EDTA were purchased from Invitrogen. L-glutamine,
poly-D-lysine hydrobromide and trypsin (type XII-S from bovine
pancreas) were purchased from Sigma, deoxyribonuclease I (DNAse I)
was from Worthington Biochemical Corporation (Lakewood, NJ) and
U18666A was from Biomol Research Laboratories (Plymouth Meeting,
PA). Culture ﬂasks (25-cm2 and 75-cm2) and 96-well plates were
purchased from BD Falcon (BD Biosciences, Bedford, MA). Bovine serum
albumin, saponin and ﬁlipin were from Sigma, paraformaldehyde was
from Fisher Scientiﬁc and Hoechst 33258 pentahydrate (bis-benzimide),
Texas Red® goat anti-rabbit IgG secondary antibody and Alexa Fluor®
488-chicken anti-mouse IgG secondary antibody were from Invitrogen.
Rabbit anti-Iba1 (ionized calcium binding adaptor molecule 1) antibody
was fromWako Pure Chemical Industries Ltd. (Osaka, Japan), andmouse
anti-MAP2 (microtubule-associated protein 2) antibody (HM-2,Ab11267) was from Abcam (Cambridge, MA). DNAse I (ampliﬁcation
grade), Oligo(dT)12–18 primer, SuperScript® II, Platinum® qPCR
SuperMix-UDG, and SYBR Green I nucleic acid gel stain were from
Invitrogen, while PCR-grade dNTPs (deoxynucleoside triphosphates)
were from Roche (Laval, QC).
2.2. Npc1+/+ and Npc1−/− mice
A breeding colony of Balb/cNctr-NpcN/+ mice was established at the
University of Alberta with breeding pairs obtained from Jackson
Laboratories (Bar Harbor, ME). The mice were maintained under
temperature-controlled conditions with a 12-h light:12-h dark cycle
and were supplied with a 9% fat breeders diet (Purina LabDiet,
Richmond, IN) andwater ad libitum. Mice homozygous and heterozygous
for the Npc1mutation will be referred to as Npc1−/− and Npc1+/−mice,
respectively, while wild-type mice will be termed Npc1+/+. Since
Npc1−/−mice are unable to produce offspring,Npc1+/−micewere used
for breeding. Prior to dissection of the brains, the Npc1 genotype of the
mouse pups was determined by PCR analysis of genomic DNA isolated
from tail clippings using the REDExtract-N-AmpTM Tissue PCR Kit
(Sigma), as described [35]. All experiments were approved by the Health
Sciences Animal Welfare Committee of the University of Alberta.
2.3. Immunohistochemical staining of mouse brain slices
Samples frombrainsof 7-week-oldNpc1+/+andNpc1−/−micewere
prepared according to Amritraj et al. [12]. Brieﬂy, mice were
anesthetized with 4% chloral hydrate, then perfused with phosphate-
buffered saline (PBS) and subsequently with 4% (w/v) paraformalde-
hyde. Brains were sectioned (20 μM) on a cryostat and processed using
the free-ﬂoating procedure [36,37]. Sectionswerewashedwith PBS and
incubated with anti-Iba1 antibody (1:1000 dilution) overnight at room
temperature. Subsequently, sections were washed with PBS and
incubated with Texas Red®-conjugated secondary antibody for 2 h at
room temperature, thenwashedwith PBS,mountedon slides in glycerol
mounting media [1 M Tris-chloride (pH 8.0), water, glycerol (1:4:5)]
and imaged using a Leica DM IRE2 ﬂuorescence microscope (Leica
Microsystems, Bannockburn, IL). The excitation wavelength was
596 nm. Images were captured using Open Lab 3.1.4 Software
(PerkinElmer, Waltham, MA) then processed using Adobe Photoshop
CS4 (San Jose, CA).
2.4. Isolation and culture of cortical glia
Glial cells were isolated from cerebral cortices of 1- to 3-day-old
Npc1+/+ and Npc1−/− mice [38]. The cortices were cleaned of
meninges and blood vessels, ﬁnely chopped, and digested in 0.25%
trypsin (Invitrogen) containing 1 mg/mL DNAse I (Worthington).
Cells were dissociated by trituration through a Pasteur pipette in
DMEM containing 10% FBS. Glial cells were pelleted by centrifugation
at 950 rpm, re-suspended in fresh DMEM containing 10% FBS, then
plated at a density of two cortices/75-cm2 ﬂask or one cortex/25-cm2
ﬂask. Cultures were maintained at 37 °C and 5% CO2 in DMEM
containing 10% FBS. Medium was replaced every 3–5 days.
2.5. Isolation and culture of cortical microglia
Microglia were isolated using the mild trypsinization method [39].
Conﬂuent cultures of mixed glial cells were maintained in ﬂasks for 3
to 4 weeks, then washed with DMEM:Ham's F12 medium (1:1) and
incubated at 37 °C with DMEM:Ham's F12 medium (1:1) containing
0.0625% trypsin for 30–60 min until the astrocyte layer lifted. Medium
and the astrocyte layer were aspirated leaving microglia attached to
the dish. For qPCR analysis, microglia were washed once with DMEM:
Ham's F12medium (1:1) containing 10% FBS, followed by awashwith
DMEM:Ham's F12 medium (1:1). Microglia were incubated in the
Table 1
qPCR primers designed to quantify mRNA levels of mouse genes involved in microglial
functions.
Gene Primer sequence
Tumor necrosis factor-α
(TNFα)
F: 5′-GTCTACTGAACTTCGGGGTGA-3′
R: 5′-CACTTGGTGGTTTGCTACGAC-3′
Interleukin-1β
(IL1β)
F: 5′-GAAGTTGACGGACCCCAAAA-3′
R: 5′-CCACGGGAAAGACACAGGTAG-3′
Inducible nitric oxide synthase
(iNOS)
F: 5′-AAGCCCCGCTACTACTCCATC-3′
R: 5′-GCCACTGACACTTCGCACAA-3′
NADPH oxidase
(NADPHox)
F: 5′-GACTGGACGGAGGGGCTAT-3′
R: 5′-ACTTGAGAATGGAGGCAAAGG-3′
Interleukin-10
(IL10)
F: 5′-GCTGGACAACATACTGCTAAC-3′
R: 5′-CCGCATCCTGAGGGTCTTC-3′
Transforming growth factor-β
(TGFβ)
F: 5′-CGCCATCTATGAGAAAACCA-3′
R: 5′-CCAAGGTAACGCCAGGAAT-3′
Glutaminase
(GLTase)
F: 5′-GTTTGCCGCATACACTGGAG-3′
R: 5′-ACATGGAGGGCTGTTCTGGA-3′
Macrophage colony-stimulating
factor receptor (M-CSFR)
F: 5′-CAAGATTGGGGACTTTGGACT-3′
R: 5′-AGAGGAGGATGCCGTAGGA-3′
Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)
F: 5′-GAGCCAAACGGGTCATCATC-3′
R: 5′-CATCACGCCACAGCTTTCCA-3′
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removal of the astrocyte layer, microglia were incubated with 0.25%
trypsin at room temperature and subsequently scraped from the dish.
DMEM:Ham's F12medium (1:1) containing 10% FBS was added to the
cell suspension, cells were pelleted at 950 rpm and microglia were re-
suspended in freshDMEM:Ham's F12medium (1:1) containing 10% FBS.
Microglia were plated in 96-well plates at a density of 62,500 cells/well.
According to immunocytochemical staining for the microglial marker
Iba1 and the astrocyte marker, glial ﬁbrillary acidic protein, as well as
labeling of nuclei by Hoechst staining, the cultures contained N90%
microglia, consistent with ~98% microglia reported previously with this
method [39].
2.6. Isolation and culture of neurons
Cerebellar granule cells (CGCs) were cultured as described [40]
with minor modiﬁcations. Brieﬂy, cerebella were dissected from 7- to
8-day-old mice, cleaned of meninges and blood vessels, ﬁnely
chopped, and digested in 0.25% trypsin containing 1 mg/mL DNAse
I. Cells were dissociated by trituration through a ﬁre-polished Pasteur
pipette in Neurobasal medium containing 10% heat-inactivated FBS.
Dissociated cells were pelleted by centrifugation at 950 rpm, re-
suspended in Neurobasal medium supplemented with 2% B27,
0.5 mM glutamine and 20 mM potassium chloride, then passed
through a 40 μm nylon cell strainer (BD Biosciences, Bedford, MA)
to remove clumped cells. Trypan blue-excluding cells were counted
using a hemocytometer and plated at a density of 31,250 cells/well in
96-well plates coated with 10 μg/mL poly-D-lysine hydrobromide.
Cells were maintained at 37 °C and 5% CO2 without re-feeding for
7 days until used for experiments.
Cortical neurons were isolated from the cortex of one-day-old mice
by the same protocol that was used for CGCs [40]. The neurons were
maintained in Neurobasal A medium (Invitrogen) supplemented with
2% B27 and 0.5 mM glutamine at 37 °C and 5% CO2 without re-feeding
for 3–4 days until used for experiments.
2.7. Filipin staining
Npc1+/+ and Npc1−/− microglia were isolated as described earlier,
plated in 96-well plates and allowed to rest overnight. The microglia
were washed with PBS, ﬁxed for 15 min in 4% (w/v) paraformaldehyde
and stained for 1.5 h with ﬁlipin (0.15 mg/mL) at room temperature.
The cells were then washed with PBS and examined with a Leica DM
IRE2 ﬂuorescencemicroscope (LeicaMicrosystems, Bannockburn, IL) at
an excitation wavelength of 351 nm. Images were captured using Open
Lab 3.1.4 Software (PerkinElmer, Waltham, MA) and processed using
Adobe Photoshop CS4 (San Jose, CA).
2.8. Measurement of TNFα secretion
Npc1+/+ and Npc1−/− microglia were isolated as described earlier,
plated in 96-well plates, and allowed to rest overnight. Medium was
removed and the cells were incubated for 24 hwith fresh DMEM/Ham's
F12medium (1:1) containing 10% FBS. Media were collected and stored
at −20 °C. Amounts of TNFα secreted into the culture medium were
determined by ELISA with a standard curve (Biosource, Camarillo, CA),
according to manufacturer's instructions.
2.9. RNA isolation and quantitative real-time PCR analysis
Npc1+/+ and Npc1−/− microglia were cultured in 75-cm2 ﬂasks for
24 h in DMEM:Ham's F12medium (1:1) thenwashedwith ice-cold PBS.
Total RNAwas isolatedusing theRNeasyMiniKit (Invitrogen)andstored
at −80 °C. RNA was treated with DNAse I (ampliﬁcation grade) to
prevent DNA contamination and cDNAwas synthesized from0.5 μg total
RNA using oligo(dT)12–18 random primers and Superscript II reversetranscriptase according to manufacturer's instructions. qPCR reactions
were performed using Platinum® Quantitation PCR supermix, SYBR
Green I and 250 nmol of gene-speciﬁc primers in a total volume of 25 μL
in 0.2 mL tubes (Axygen, Union City, CA). Transcripts were detected by
qPCR with a Rotor-Gene 3000 instrument (Montreal Biotech, Montreal,
QC) and data were analyzed with Rotor-Gene 6.0.19 software. Amounts
of transcriptsweredeterminedusing thestandard curvemethod. Intron-
spanning primers were designed using OLIGO 6.71 software (Cascade,
CO) and speciﬁcitywas conﬁrmedwith theNCBI BLASTnucleotide query
tool, by melt curve analysis, and by agarose gel electrophoresis. All
primers were synthesized by IDT Technologies (San Diego, CA)
(sequences shown in Table 1). Data were normalized to levels of control
mRNA encoding glyceraldehyde-3-phosphate dehydrogenase.
2.10. Microglia–neuron co-cultures
Npc1+/+ and Npc1−/− CGCs were cultured in 96-well plates for
7 days. Npc1+/+ and Npc1−/− microglia were isolated as described
earlier and plated directly on top of the CGC cultures at densities that
were either 25% or 50% of the CGC density (7800 cells/well or
15,600 cells/well, respectively). The co-cultures were given Neurobasal
medium supplemented with 2% B27, 0.5 mM glutamine and 20 mM
potassium chloride. After 24 h, cells were ﬁxed with 4% (w/v)
paraformaldehyde then washed with PBS and permeabilized for 1 h at
room temperature with PBS containing 1% bovine serum albumin and
0.05% saponin. Subsequently, the cells were incubatedwith anti-MAP-2
(1:500) and anti-Iba1 (1:500) antibodies diluted in PBS containing 1%
bovine serum albumin and 0.05% saponin for 1 h at room temperature.
The cells were washedwith PBS then incubatedwith Alexa Fluor® 488-
and Texas Red®-conjugated secondary antibodies (1:200) for 45 min at
room temperature in the dark. Cells were rinsed with PBS, stained for
12 min with 0.5 μg/mL Hoechst 33258, and examined using a Leica DM
IRE2 ﬂuorescence microscope (Leica Microsystems, Bannockburn, IL).
The excitation wavelength was 495 nm for Alexa Fluor® 488, 596 nm
for Texas Red® and 351 nm for Hoechst stain. Images were captured
using Open Lab 3.1.4 Software (PerkinElmer, Waltham, MA) and the
number of apoptotic cells stained by the neuronal marker MAP2 was
quantiﬁed.
2.11. Phagocytosis assay
Npc1+/+ and Npc1−/− microglia were plated in 96-well plates and
allowed to rest overnight after which medium was replaced with fresh
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latex beads (Sigma, L4655) at a concentration of 3.1×106 beads/well
(50 beads/microglia). Microglia were incubated with the beads at 37 °C
for 2 h, then washed 3 times with ice-cold PBS. Microglia were examined
using a Leica DM IRE2 ﬂuorescence microscope (Leica Microsystems,
Bannockburn, IL). The excitation wavelength for the beads was 505 nm.
Phase and ﬂuorescent images were captured using Open Lab 3.1.4
Software (PerkinElmer, Waltham, MA) and the number of beads
associated with the microglia was quantiﬁed. As a control for beads that
had bound to microglia without being internalized, parallel experiments
were performed at 4 °C to block phagocytosis. The number of beads
associated with microglia at 4 °C was subtracted from the number of
beads associated with microglia at 37 °C.2.12. Statistical analysis
The statistical signiﬁcance of differences was determined using the
Student's t test. Differences were considered signiﬁcant for Pb0.05.Fig. 1. Active microglia accumulate in the cerebellum and cortex of Npc1−/− mice.
Immunohistochemical staining ofmicroglia in brains of 7-week-old Npc1+/+ (panels A, C)
and Npc1−/− (panels B, D) mice. Brains were ﬁxed. Cerebella (panels A, B) and cerebral
cortices (panels C, D) were sectioned then labeled with ﬂuorescent antibodies raised
against Iba1, a microglial marker. Shown are representative images from independent
preparations from 3 mice.3. Results
3.1. Microglia with an active morphology accumulate in Npc1−/−
mouse brains
Since microglia have been implicated in several neurodegenerative
disorders, including NPC disease, we investigated the involvement of
microglia in neuronal death in NPC disease. We ﬁrst performed
immunohistochemical analysis of brain slices from the cerebellum and
cerebral cortex ofNpc1+/+ andNpc1−/−mice. Sectionswere taken from
7-week-old mice and immunostained for the microglial marker Iba1.
Mice of this age were selected since overt signs of NPC neurological
disease are apparent in 7-week-old mice. In the Npc1+/+ cerebellum
(Fig. 1A) and cortex (Fig. 1C) microglia were primarily detected in a
ramiﬁed, resting morphology. In the Npc1−/− cerebellum (Fig. 1B) and
cortex (Fig. 1D), however, the number of microglia was markedly
increased, and the Npc1−/− microglia had swollen cell bodies and
shortened processes, indicating that the microglia were activated. Thus,
NPC1 deﬁciency in the brain markedly increases the number of
microglia, and themorphology of themicroglia shifts to amore activated
phenotype.Fig. 2. Altered intracellular distribution of unesteriﬁed cholesterol in Npc1−/−
microglia. Microglia were isolated from mixed glial cultures from Npc1+/+ (panel A)
and Npc1−/− (panel B) mice. The microglia were allowed to rest overnight then stained
with ﬁlipin for detection of unesteriﬁed cholesterol. Shown are representative images
from 3 independent microglial preparations.3.2. Intracellular cholesterol distribution is altered in Npc1−/− microglia
The compound U18666A induces cholesterol sequestration in LE/Ls
of cells, similar to the cholesterol trafﬁcking defect in NPC1-deﬁcient
cells [41]. In preliminary experiments we incubated primary cultures of
Npc1+/+ microglia with U18666A (3 μM) for 6 h and examined the
intracellular distribution of unesteriﬁed cholesterol by ﬁlipin staining.
As expected, U18666A induced a bright punctate staining pattern in
Npc1+/+ microglia upon ﬁlipin staining (data not shown). This
intracellular sequestration of cholesterol is typical of that exhibited by
NPC-deﬁcient cells such as ﬁbroblasts [3], sympathetic neurons [4] and
astrocytes [5]. We next used ﬁlipin staining to compare the distribution
of cholesterol in primarymicroglia isolated from Npc1+/+ and Npc1−/−
mice. The Npc1+/+microglia showed a faint, diffuse intracellular ﬁlipin
staining for cholesterol (Fig. 2A) that is likely attributable to cholesterol
in the endosomal recycling compartment, a region of the cell that is
enriched in cholesterol [42]. In contrast, Npc1−/− microglia showed
markedly increased intracellular ﬁlipin staining in a punctate pattern
characteristic of that of other NPC-deﬁcient cells in which cholesterol
becomes sequestered in the LE/L [3,4] (Fig. 2B). These data show that
NPC1 deﬁciency in the microglia causes the intracellular sequestration
of cholesterol.
Fig. 4. Npc1+/+ and Npc1−/−microglia secrete similar amounts of TNFα in vitro. Primary
culturesofNpc1+/+ (blackbars) andNpc1−/− (whitebars)microgliawereestablished. The
microglia were incubated with fresh medium for 24 h after which the amount of TNFα
secreted into the medium was measured by ELISA. Values are means±S.E. of 3
independentmicroglial preparations, each analyzed induplicate. PN0.05 (Student's t test).
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NPC1-deﬁcient microglia
Microglia produce pro- and anti-inﬂammatory cytokines as well as
molecules involved in oxidative stress and cell proliferation. To
determine if NPC1 deﬁciency altered the expression of these factors,
we quantiﬁed levels of mRNAs encoding some of these proteins in
primary microglia isolated from Npc1−/− and Npc1+/+ mice. The
amounts ofmRNAs encoding thepro-inﬂammatory cytokines TNFα and
interleukin-1β (IL1β) were not signiﬁcantly different betweenNpc1−/−
and Npc1+/+ microglia (Fig. 3A). Nor did NPC1 deﬁciency increase the
amount of TNFα secreted into the medium by microglia during a 24 h
period (Fig. 4). Moreover, levels of mRNAs encoding markers of
oxidative stress, such as inducible nitric oxide synthase (iNOS, which
produces nitric oxide [43]), and NADPH oxidase (NADPHox, which
produces superoxide [44], were similar in Npc1−/− and Npc1+/+
microglia (Fig. 3B). Thus, NPC1 deﬁciency does not appear to increase
the expression of genes involved in the generation of reactive oxygen
species in microglia. However, the amount of mRNA encoding the
anti-inﬂammatory cytokine interleukin-10 (IL10) was ~60% lower
in Npc1−/− microglia than in Npc1+/+ microglia (Fig. 3C), although
the level of mRNA encoding another anti-inﬂammatory cytokine,
transforming growth factor-β (TGFβ), was not different between
Npc1−/− and Npc1+/+ microglia (Fig. 3C). Additionally, we quanti-
ﬁed the mRNAs encoding glutaminase (which produces glutamate
that can lead to excitotoxic death [45]) and the macrophage colony-
stimulating factor receptor (which is involved in microglial prolif-
eration and activation [46]). No signiﬁcant differences in expressionFig. 3. Expression ofmRNAs encoding pro- and anti-inﬂammatory cytokines andmRNAs assoc
(black bars) and Npc1−/− (white bars) mouse microglia were isolated. qPCR mRNA analys
(IL1ß)]; panel B, oxidative stress genes [inducible nitric oxide synthase (iNOS) and NADPH
transforming growth factor-ß (TGFß)]; and panel D, excitotoxic [glutaminase (GLTase)] and pr
were normalized to the amount of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) m
was analyzed in triplicate. **, Pb0.01 according to Student's t test.of these genes were observed between Npc1−/− and Npc1+/+
microglia (Fig. 3D). These results indicate that although NPC1
deﬁciency in the CNS induces an activated morphology in microglia,
the production of pro-inﬂammatory cytokines and markers of
oxidative stress was not increased in primary cultures of Npc1−/−
microglia. On the other hand, since the level of IL10 mRNAwas loweriatedwith oxidative stress, excitotoxicity and proliferation. Primary cultures ofNpc1+/+
is was performed for: panel A, pro-inﬂammatory cytokines [TNFα and interleukin-1ß
oxidase (NADPHox)]; panel C, anti-inﬂammatory cytokines [interleukin-10 (IL10) and
oliferative [macrophage colony-stimulating factor (M-CSFR)] genes. Amounts ofmRNAs
RNA. Data are means±S.E. from 3 independent microglial preparations, each of which
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functions, or the suppression of an inﬂammatory response, might be
impaired in Npc1−/− microglia.
3.4. Neuronal apoptosis is not increased by NPC1 deﬁciency in microglia–
neuron co-cultures
Since NPC disease is characterized by extensive neurodegeneration,
we determined whether or not NPC1 deﬁciency in isolated neurons
compromised neuronal survival. We cultured cerebellar granule cells
(CGCs) from Npc1+/+ and Npc1−/−mice for 7 days, then quantiﬁed the
extent of neuronal death by staining the cells with Hoechst stain to
detect condensed nuclei that are typical markers of apoptotic cell death
[47]. The percentage of apoptotic neurons in the CGC cultureswas ~20%
and was independent of Npc1 genotype (Fig. 5). Similar results were
obtained in preliminary experiments with primary cultures of cortical
neurons, as well as sympathetic neurons, isolated from the superior
cervical ganglion of Npc1+/+ and Npc1−/−mice. Thus, NPC1 deﬁciency
does not decrease survival of primary cultures of these types of neurons.
To determine if the intracellular sequestration of cholesterol that we
observed inNpc1−/−microglia impaired neuron survival, for example by
inducing the secretion of factors that are toxic to neurons, we performed
several types of co-culture experiments. First,we incubatedNpc1+/+ and
Npc1−/− CGCs for 24 h with culture medium that had been conditioned
for 24 h by Npc1+/+ and Npc1−/−microglia. Cell death was assessed by
Hoechst staining. The extent of cell death was the same (25−30%) for
Npc1+/+ and for Npc1−/− neurons incubated for 24 h with medium
conditioned by Npc1+/+ or Npc1−/−microglia.
We also established co-cultures of neurons (CGCs) with microglia.
The microglia were plated at either a low density (25% of the number
of neurons) or a high density (50% of the number of neurons), directly
on top of the CGC cultures. Different combinations of Npc1 genotypes
of neurons and microglia were plated together so that co-cultures of
Npc1+/+ or Npc1−/− CGCs were established with either Npc1+/+ or
Npc1−/− microglia. After 24 h, the cells were ﬁxed and stained for
speciﬁc neuronal (MAP2) and microglial (Iba1) marker proteins. The
percentage of Npc1−/− neurons that were apoptotic, according to
Hoechst staining, was similar (20–23%) when the neurons were co-
cultured with a low density of either Npc1+/+ or Npc1−/− microglia
(Fig. 6A). In addition, when Npc1+/+ CGCs were cultured with a low
density of microglia the extent of neuronal death (18–22%) was
independent of Npc1 genotype of the microglia (Fig. 6A). Similarly,
when Npc1−/− neurons were cultured with a high concentration ofFig. 5. Survival of cerebellar granule neurons is not impaired by NPC1 deﬁciency.
Cerebellar granule neurons (CGCs) from Npc1+/+ (black bars) and Npc1−/− (white
bars) mice were cultured for 7 days, ﬁxed with paraformaldehyde and nuclei were
stained with Hoechst stain. The number of apoptotic nuclei from N500 cells in each
preparation is given as a percentage of total number of neurons. Data are means±S.E.
from 3 independent preparations of CGCs, each of which was analyzed in duplicate.
PN0.05 (Student's t test).microglia, the number of neurons that were apoptotic (12–17%) was
independent of the Npc1 genotype of the microglia (Fig. 6B). On the
other hand, the number of apoptoticNpc1+/+ neuronswas signiﬁcantly
lower when the neurons were cultured in the presence of a high
concentration of Npc1−/− microglia compared to Npc1+/+ microglia
(10% versus 19%, Pb0.001; Fig. 6B). In a physiological context, in the
brains of Npc1−/− mice, Npc1−/− microglia would interact with
Npc1−/−, but not Npc1+/+, neurons, whereas in Npc1+/+ mice
Npc1+/+ microglia would interact with Npc1+/+, but not Npc1−/−,
neurons. When the data in Fig. 6 are compared in this way, the number
of apoptotic neurons was signiﬁcantly lower (Pb0.01) when Npc1−/−
neurons were cultured in the presence of a high concentration of
Npc1−/− microglia (12.3±1.7%) than when Npc1+/+ neurons were
cultured with a high concentration of Npc1+/+microglia (19.8±1.5%);
however, no difference in apoptosis was apparent when the neurons
were co-culturedwith low concentrations of microglia. The reasonwhy
high concentrations of Npc1−/−microglia appear to protect CGCs is not
clear althoughunder all culture conditions neuronal deathwas very low
and survival of the CGCs was 85-90%. Thus, Npc1−/− microglia do not
induce neuron death in co-cultures of microglia and neurons, support-
ing the view that Npc1−/− microglia do not directly cause neuronal
death.
The conditions we used for culture of neurons were selected for
maximal survival. We, therefore, considered the possibility that the
optimal amounts of growth factors present in the neuronal culture
medium had prevented factors secreted by the microglia from
inducing neuronal apoptosis. Consequently, we performed experi-
mentswithmicroglia and cortical neurons co-cultured in the presence
of Neurobasal A medium lacking any growth supplements. Under
these conditions, neuronal apoptosis was ~50% after 48 h and was
independent of Npc1 genotype of both neurons and microglia.
We conclude that the survival of CGCs and cortical neurons cultured
in vitro does not appear to be inherently reduced by NPC1 deﬁciency.Fig. 6. NPC1 deﬁciency in microglia does not cause neuron death in microglia–neuron
co-cultures. Primary cultures of Npc1+/+ and Npc1−/− CGCs were co-cultured with
Npc1+/+ (black bars) or Npc1−/− (white bars) microglia. The microglia were plated at
densities that were either low (panel A: 25% of the number of neurons) or high (panel B:
50% of the number of neurons) in co-culture with 7-day-old neuronal cultures. After
24 h, the cells were ﬁxed and stained with anti-MAP2 antibodies (marker of neurons),
anti-Iba1 antibodies (marker of microglia) and Hoechst stain (marker of nuclei). Data
are means±S.E. of the number of apoptotic nuclei in neurons as a percentage of total
number of neurons, for N1000 neurons from 3 independent microglia preparations and
2 independent CGC preparations. **, Pb0.001 (Student's t test).
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when these microglia are co-cultured with either Npc1−/− or Npc1+/+
neurons.3.5. Phagocytosis is not impaired in Npc1−/− microglia
Microglia are phagocytic cells of the CNS that engulf degenerating
cells and other debris [19]. Therefore, to determine if the sequestra-
tion of cholesterol within Npc1−/− microglia altered their phagocytic
capability, microglia were incubated for 2 h with ﬂuorescent latex
beads, then extensively washed and the number of beads that were
internalized by the microglia was quantiﬁed. As a control for beads
that had attached to the cells, but had not been internalized, parallel
cultures were incubated at 4 °C in order to block phagocytosis. The
number of cell-associated beads at 4 °C was subtracted from the
number of beads associated with the cells at 37 °C. Fig. 7 shows that
the number of latex beads phagocytosed by Npc1−/− microglia and
Npc1+/+ microglia was not signiﬁcantly different. Thus, according to
this criterion of microglial activity, phagocytosis by microglia is not
impaired by NPC1 deﬁciency.4. Discussion
4.1. Accumulation of active microglia in NPC1-deﬁcient brains
Inappropriate activation of microglia has been implicated in several
neurodegenerative disorders including NPC disease [13,33,34]. Consis-
tent with the ﬁndings of others [13,48], we observed a marked
accumulation of microglia with activated morphology in Npc1−/−
mouse brains. As in otherNPC1-deﬁcient cells,ﬁlipin staining revealed a
pronounced intracellular sequestration of unesteriﬁed cholesterol in
Npc1−/− microglia. However, the levels of mRNAs encoding pro-
inﬂammatory cytokines and oxidative stress proteins were not
increased by NPC1 deﬁciency in primary cultures of microglia. These
data suggest that the microglia that accumulate in NPC1-deﬁcient
mouse brains are not activated solely by NPC1 deﬁciency in the
microglia, but by an additional insult, such as neuron death. Evidence is
accumulating that macrophages can cross the blood-brain barrier from
the circulation, particularly in states of disease and inﬂammation
[49,50]. Thus, the proliferation of Iba1-positive cells in NPC1-deﬁcient
mouse brains might also be due, at least in part, to an inﬁltration of
macrophages since Iba1 is expressed inbothmicroglia andmacrophages
[51,52].Fig. 7. Phagocytosis of latex beads is not impaired in Npc1−/−microglia. Microglia were
isolated from Npc1+/+ (black bar) or Npc1−/− (white bar) mice and allowed to rest
overnight. Carboxylate-modiﬁed poylstyrene latex beads were added to the culture
medium and incubated with the microglia for 2 h at 37 °C. The cells were extensively
washed and the number of beads per microglial cell was quantiﬁed. As a control for
binding of beads in the absence of uptake, microglia were incubated with beads for 2 h
at 4 °C, and these values were subtracted from the total number of beads associated
with the microglia at 37 °C. Values are means±S.E. from N600 microglia in 3
independent experiments. PN0.05 (Student's t test).4.2. Consequences of NPC1 deﬁciency on cytokine production by microglia
Microglia are the major source of TNFα in the CNS [53] and TNFα is
often associated with inﬂammation-mediated cell death. Since in-
creased levels of mRNAs encoding TNFα (and other genes involved in
the TNFα death pathway) have been detected in brains [9] and livers
[54,55] of Npc1−/− mice, we compared the level of TNFα mRNA in
Npc1−/− and Npc1+/+ primary microglia. Neither the amount of TNFα
mRNA in microglia, nor the amount of TNFα secreted by the microglia,
was increased by NPC1 deﬁciency. In addition, immunoblotting for
TNFα inNpc1−/− andNpc1+/+primarymicroglia revealednodifference
in the amount of intracellular TNFα. It is likely, therefore, that the
amount of TNFαmRNA [9] is increased in Npc1−/−mouse brains upon
activation of the microglia in response to neuron death in the intact
brain. In addition, the increased amounts of TNFα mRNA in NPC1-
deﬁcient brainsmight be, at least in part, a consequence of the increased
number of activated microglia in the brain. Our data show that in
primary cultures of microglia NPC1 deﬁciency does not increase the
production of pro-inﬂammatory cytokines, such as TNFα. These
observations are consistent with the recent studies of Lopez et al. in
which the inducible expression of NPC1 in speciﬁc types of neurons in
the brains of Npc1−/−mice rescued the neurodegeneration despite the
presence of Npc1−/− microglia [56]. Furthermore, the highest concen-
tration of activated microglia in Npc1−/−mouse brains was detected in
areas of the brain in which neurodegeneration was most pronounced
[56].
Ultimately, the role ofmicroglia is tomaintain brain health. Although
microglia are capable of exerting cytotoxic effects, microglia can also be
neuroprotective [25–27]. For example, microglia secrete IL10, an anti-
inﬂammatory cytokine that decreases the synthesis of pro-inﬂammatory
cytokines, such as TNFα and interleukin-1β, as well as reactive oxygen
species, both in vitro and in vivo[57–60]. Following lipopolysaccharide-
induced inﬂammation in the rat cerebral cortex, IL10 immunostaining
was primarily detected in activated microglia [61]. When IL10 activity
was abrogated with anti-IL10 antibodies, neuronal death increased, as
did the amounts of reactive oxygen species and pro-inﬂammatory
cytokines [61]. IL10 can also prevent excitotoxic death of neurons,
apparently via inhibition of pro-apoptotic proteins such as caspase-3
[62,63]. Our studies revealed that NPC1 deﬁciency in primary cultures of
microglia signiﬁcantly reduced the level of themRNA encoding IL10. It is
possible that the decrease in the amount of IL10mRNA thatwe observed
in Npc1−/− microglia attenuates the ability of the microglia to prevent
neuronal death. Thus, the reduction in IL10 production might lead to
chronic activation ofNpc1−/−microglia and the prolonged production of
pro-inﬂammatory cytokines and other neurotoxic molecules that would
eventually contribute to neuron death in the CNS.
4.3. Microglia–neuron co-cultures
Activemicroglia have been detected in NPC1-deﬁcientmouse brains
prior to any detectable neurodegeneration [13], suggesting that NPC1-
deﬁcient microglia might initiate neuron death in NPC disease. Our
experiments with microglia–neuron co-cultures demonstrate that the
survival of CGCs is not compromised when the neurons are cultured in
the presence of Npc1−/−, instead of Npc1+/+, microglia. This observa-
tion is consistent with the idea that NPC1 deﬁciency in microglia does
not initiate neuron death. Interestingly, in the presence of high
concentrations of microglia, less neuronal apoptosis occurred when
Npc1−/− neurons were cultured with Npc1−/− microglia, than when
Npc1+/+ neurons were cultured with Npc1+/+ microglia. Whether or
not this neuroprotective effect would be physiologically relevant is not
clear since the number of apoptotic neurons was only 10–20% under all
culture conditions. Thus, our results support in vivo studies in which
Purkinje cell death in NPC disease was shown to be cell autonomous
[48,56,64]. For example, NPC1 deﬁciency in Purkinje cells alone caused
Purkinje cell death despite other cells of the brain, including microglia,
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expressed speciﬁcally in neurons in different regions of the brain of
Npc1−/− mice, such as the thalamus, cholesterol accumulation in the
neurons was eliminated, neurodegeneration was prevented, and glial
activity was reduced [56]. Our results expand on these ﬁndings by
showing that in microglia–neuron co-cultures, NPC1 deﬁciency in
microglia does not cause neuronal death.
Nevertheless, it is important to note that our ﬁndings do not
preclude the involvement of microglia in NPC disease progression since
extensive interactions occur among the different cell types within the
intact brain. Thus, although NPC1 deﬁciency in neurons appears to be
the primary cause of neuronal death in NPC-deﬁcient brains, chronic
microglial activation and inﬂammation in the CNS might occur in
response to neuron death which might exacerbate the neurodegenera-
tion. Indeed, anti-inﬂammatory therapy delayed the onset of neurolog-
ical symptoms and prolonged the lifespan of Npc1−/− mice [65]. Thus,
our data support the view that the loss of NPC1 in microglia is not the
primary cause of CNS pathogenesis in NPC disease.
5. Conclusions
We show that Npc1−/− microglia sequester cholesterol intracellu-
larly. Although microglia with an activated morphology proliferate in
NPC1-deﬁcient mouse brains, NPC1 deﬁciency in primary cultures of
microglia does not increase the secretion of the pro-inﬂammatory
cytokine, TNFα, or the level ofmRNAs encoding oxidative stress genes in
microglia. On the other hand, the level of mRNA encoding IL10, an anti-
inﬂammatory cytokine,was lower inNpc1−/−microglia than inNpc1+/+
microglia. Our data also show that the survival of primary cultures of
neurons was not impaired by NPC1 deﬁciency. Furthermore, Npc1−/−
microglia did not induce neuron death in microglia–neuron co-cultures.
Thus, whileNpc1−/−microgliamight exacerbate theneurodegeneration
in Npc1−/− brains, NPC1 deﬁciency in microglia alone appears to be
insufﬁcient to initiate neuron death.
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